Sanofi Capital Reinvestment Ratio
Sanofi capital reinvestment ratio. Sanofi (SNYN) has a Capital Reinvestment Ratio of 0.33x as of December 2025, meaning it reinvests 0% of its operating cash flow (MX$10.75 Billion) in capital expenditures (MX$3.54 Billion). See Sanofi free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Sanofi (2013–2025)
Capital reinvestment ratio of Sanofi from 2013 to 2025. This chart tracks Sanofi's Capital Reinvestment Ratio across 13 annual periods. See SNYN financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Sanofi Capital Reinvestment Ratio by Year (2013–2025)
Sanofi capital reinvestment ratio by year from 2013 to 2025. For the full cash flow conversion analysis, see SNYN operating cash flow.
| Year | Reinvestment Ratio | Operating CF (MXN) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.33x | MX$10.75 Billion | MX$3.54 Billion | ▼ -6.5% |
| 2024 | 0.35x | MX$9.08 Billion | MX$3.19 Billion | ▲ +19.3% |
| 2023 | 0.29x | MX$10.26 Billion | MX$3.02 Billion | ▲ +93.2% |
| 2022 | 0.15x | MX$10.53 Billion | MX$1.61 Billion | ▲ +8.5% |
| 2021 | 0.14x | MX$10.52 Billion | MX$1.48 Billion | ▼ -16.9% |
| 2020 | 0.17x | MX$7.42 Billion | MX$1.25 Billion | ▼ -1.4% |
| 2019 | 0.17x | MX$7.71 Billion | MX$1.32 Billion | ▼ -32.8% |
| 2018 | 0.26x | MX$5.55 Billion | MX$1.42 Billion | ▲ +35.6% |
| 2017 | 0.19x | MX$7.38 Billion | MX$1.39 Billion | ▼ -29.2% |
| 2016 | 0.27x | MX$7.84 Billion | MX$2.08 Billion | ▲ +97.1% |
| 2015 | 0.13x | MX$8.92 Billion | MX$1.20 Billion | ▼ -28.6% |
| 2014 | 0.19x | MX$7.69 Billion | MX$1.45 Billion | ▲ +0.6% |
| 2013 | 0.19x | MX$6.95 Billion | MX$1.31 Billion | — |